Exploiting a vulnerability in an aggressive leukemia affecting babies
New work finds that the cells that cause relapse in MLL-rearranged B-ALL can morph between two states, and that targeting one of these...
Jun 2, 2022
Research lays a foundation for prevention of the most common childhood cancer
Scientists at St. Jude Children’s Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic...
Feb 8, 2022
Immunotherapy drug improves outcomes for some children with relapsed leukemia
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for...
Dec 11, 2019